Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lidds ABFRA:5LD Cash Ratio is 3.51 as of Sep. 2025, which is 3% below its 10-year median of 3.62. The stock has 2 warning signs investors should review.
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Lidds AB Cash Ratio Related Terms
Lidds AB Cash Ratio Historical Data
* Premium members only.
The historical data trend for Lidds AB's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:5LD vs VRTX, REGN, ALNY: Cash Ratio Comparison
For the Biotechnology subindustry, Lidds AB's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lidds AB Cash Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Lidds AB's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Lidds AB's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lidds AB (FRA:5LD) has a Cash Ratio of 3.51 as of Sep. 2025. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Lidds AB and its competitors. This is near median its historical median of 3.62. Over the past decade, Lidds AB's Cash Ratio has ranged from 0.47 to 8.90.
Is Lidds AB's Cash Ratio too high?
Lidds AB's current Cash Ratio of 3.51 is near median its 10-year median of 3.62. Over the past 10 years, this metric has ranged from a low of 0.47 to a high of 8.90. The Biotechnology industry median Cash Ratio is 2.93. Lidds AB's value of 3.51 is 19.8% above this industry median.
How does Lidds AB's Cash Ratio compare to VRTX and REGN?
Lidds AB's Cash Ratio of 3.51 can be compared against companies in the Biotechnology industry. The industry median Cash Ratio is 2.93. Lidds AB's value of 3.51 is 19.8% above this benchmark. Historically, Lidds AB's own Cash Ratio has ranged from 0.47 to 8.90 over the past decade. While the company's 10-year median is 3.62 vs. the industry median of 2.93, Lidds AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Biotechnology company?
The median Cash Ratio among Biotechnology companies is 2.93, based on 1,383 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lidds AB's current Cash Ratio of 3.51 is 19.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Lidds AB and its competitors. For the Biotechnology industry, the median Cash Ratio is 2.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lidds AB's current Cash Ratio is 3.51, which is near median its own 10-year median of 3.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lidds AB stock overvalued right now?
Lidds AB (FRA:5LD) has a current Cash Ratio of 3.51. The current Cash Ratio is 3.51, which is near median its 10-year median of 3.62 and 19.8% above the Biotechnology industry median of 2.93. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Lidds AB (FRA:5LD), the current Cash Ratio is 3.51 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Lidds AB is a Sweden-based drug delivery company focused on its proprietary NanoZolid technology platform. The NanoZolid system is used to formulate drugs for local administration with controlled and sustained release over extended periods. The company offers this technology to partners and is also developing its own pipeline of drug candidates, prominently in oncology, where the platform is used to enable localized and sustained drug delivery. It has a pipeline with several projects in clinical development, both in early- and late-stage clinical phases, and projects about to enter clinical development.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5LD has been successfully added to your 
